glycogen synthase kinase-3β (GSK-3β), negatively regulate and 1,2-dimethylhydrazine (DMH) induce colon tumors in β-catenin (9,10). In the absence of Wnt signal, GSK-3β the rat that contain mutations in β-catenin, but the pattern phosphorylates β-catenin at critical Ser/Thr residues, targeting of mutation differs from that found in human colon cancers.
it for ubiquitination by β-TrCP and proteosomal degradation In both species, mutations affect the glycogen synthase (11, 12) . In primary human colon tumors and colorectal cell kinase-3β consensus region of β-catenin, but whereas they lines, mutations in CTNNB1 substitute the critical Ser/Thr directly substitute critical Ser/Thr phosphorylation sites in residues in the GSK-3β region and stabilize β-catenin, leading human colon cancers, the majority of mutations cluster to the accumulation of β-catenin-TCF-LEF complexes in the around Ser33 in the rat tumors. Two dietary phytochemnucleus (3-5). This complex is able to activate various target icals, chlorophyllin and indole-3-carbinol, given post-initigenes, including c-MYC, c-JUN and cyclin D1 (13) (14) (15) .
ation, shifted the pattern of β-catenin mutations in rat
In addition to genetic factors, a major risk factor for colon tumors induced by IQ and DMH. Specifically, 17/39 colorectal cancer is diet, and approximately one third of human (44%) of the β-catenin mutations in groups given carcinocolorectal cancers might be prevented through appropriate gen plus modulator were in codons 37, 41 and 45, and dietary modification (16) . The human diet contains mutagens substituted critical Ser/Thr residues directly, as seen in and carcinogens, as well as cancer chemopreventive comhuman colon cancers. None of the tumors from groups pounds (17) (18) (19) (20) . Two such compounds that have been of given carcinogen alone had mutations in these codons.
interest in this laboratory are indole-3-carbinol (I3C), a Interestingly, many of the mutations that substituted critical constituent of brassica vegetables, and chlorophyllin (CHL), Ser/Thr residues in β-catenin were from a single group a water-soluble salt of chlorophyll. Previous studies have given DMH and 0.001% chlorophyllin, in which a statisticdetermined that during the initiation phase, I3C and CHL ally significant increase in colon tumor multiplicity was exhibit anti-carcinogenic properties by altering carcinogen observed compared with the group given DMH only. These metabolizing enzymes or via molecular complex formation, tumors had marked over-expression of cyclin D1, c-myc respectively (21, 22) . However, the post-initiation effects of and c-jun mRNA and c-Myc and c-Jun proteins were these compounds are generally less well characterized, and a strongly elevated compared with tumors containing wildfew studies have provided evidence for tumor promotion or type β-catenin. The results indicate that the pattern of β-enhancement depending upon the initiator, exposure protocol catenin mutations in rat colon tumors can be influenced and species (see refs 21 and 22 for mini-reviews). by exposure to dietary phytochemicals administered postIn this report, we examined the pattern of β-catenin mutainitiation, and that the mechanism might involve the altered tions in colon tumors from rats induced with 2-amino-3-expression of β-catenin/Tcf/Lef target genes.
methylimidazo[4,5-f]quinoline (IQ) or 1,2-dimethylhydrazine (DMH) and post-treated with CHL or I3C. The carcinogen DMH is a synthetic compound that induces tumors of the Introduction colon and small intestine in the rat (23), whereas IQ is Colorectal cancer is a leading cause of cancer-related deaths generated during normal cooking of meat and fish (24) , and in the US (1). Cancers of the colon and rectum are believed produces tumors of the liver, colon, small intestine, Zymbal's to arise via mutations in oncogenes, tumor suppressor genes gland and skin (25) . Colon tumors induced by DMH contain and genes that control DNA repair and replication. Among Ki-ras mutations but lack genetic changes in p53 (26), whereas those induced by IQ lack mutations in Ki-ras and p53 genes, and have few microsatellite or Apc mutations (27). However, altered by post-initiation treatment with CHL or I3C. 
a Rats were initiated with carcinogen for 5 weeks; IQ was administered in the diet (AIN-93) at a concentration of 0.03%, whereas DMH was injected s.c. once a week (20 mg/kg body wt). Starting one week after the last carcinogen treatment until the end of the study at 1 year, rats were given CHL in the drinking water or I3C in the diet, at concentrations shown in the table (see column 1). Most of the colon tumors in this study were identified as adenocarcinomas, as reported elsewhere (31 screened by PCR-SSCP analysis and the mutations confirmed by sequencing (Figure 1 ; Table I ). Genetic changes were found Mutation screening and sequencing Tissue samples were extracted with DNAzol genomic isolation reagent in codons 32, 33, 34, 37, 41 and 45 of Ctnnb1, and substituted (Molecular Research Center), and the DNA was quantified using a Shimadzu critical Ser/Thr residues or their adjacent amino acids within UV-2401PC spectrophotometer. Amplification of the region corresponding the GSK-3β region of β-catenin. The majority of these tumors with the GSK-3β region of β-catenin was carried out using the polymerase analyzed were from groups given DMH; β-catenin mutations chain reaction (PCR), according to the conditions described before (28) .
were detected in 44/119 (37%) of the DMH-induced tumors Single-strand conformation polymorphism (SSCP) screening was performed using the GenePhor electrophoresis system (Amersham Pharmacia Biotech). versus 6/13 (46%) of the tumors from groups given IQ (Table   DNA (6 ng/well) was run at 15°C, 600 V, 25 mA and 15 W for 1.5 h, and I, final column). Due to the low number of IQ-induced tumors, the gel was silver stained. Bands exhibiting altered migration were cut from no information was obtained on the effect of I3C or CHL the gel, re-amplified and cleaned using Wizard PCR Preps (Promega). Samples treatment on the spectrum or frequency of β-catenin mutations.
were sequenced in both directions on an ABI Prizm TM model version 3.3 automated sequencer.
In the DMH groups, no differences were seen in the overall frequency of β-catenin mutations when the combined
RT-PCR
groups given CHL or the combined groups given I3C were Frozen tumor samples were added to the Micro-FastTrack 2.0 kit (Invitrogen) in order to isolate mRNA, and either Superscript II (Gibco BRL) or the compared with the positive control group given carcinogen Promega RT system was used to synthesize cDNA. Primer sequences and
alone. An inverse relationship between concentration of CHL PCR conditions were as published for hprt and cyclin D1 (32), c-myc (33) and β-catenin mutation frequency was observed; thus, 23, 44 and c-jun (34) . and 50% of the tumors had mutations for 0.1, 0.01 and 0.001%
Western blotting
CHL groups, respectively, but this trend proved not to be Tumor tissue was homogenized at room temperature in RIPA lysis buffer statistically significant when the analysis included the group (Qiagen) and centrifuged at 14 000 g for 2 min through the QIAshredder given DMH alone. In the group given DMH alone, 10/30 (Qiagen). Protein (15-20 µg) was run on a 4-12% Bis-Tris gel (Novex) and transferred onto a nitrocellulose membrane. After overnight blocking, the (33%) of the colon tumors had β-catenin mutations, and membrane was first incubated for 1 h with primary antibody, then washed sequencing revealed that these were clustered in codons 32, and incubated with secondary antibody conjugated with horseradish peroxidase 33 and 34; 8/10 (80%) were G→A transition mutations (Bio-Rad), and finally developed using ECL reagents 1 and 2 (Amersham).
affecting codons 32 and 34 (Table I) . Codons 32 and 34 also
Imaging and quantification of the data was by an Alphalnnotech photodocumentation system. The primary antibodies used were as follows: β-were hotspots for mutation in groups given carcinogen and post-treated with CHL or I3C; however, in marked contrast to the results seen after treatment with carcinogen alone, 17/39 (44%) of the genetic changes directly altered codons 37, 41 or 45.
When the results from this study were summarized in terms of the amino acid substitutions in the β-catenin protein, a shifted pattern of mutations was clearly apparent in the groups given CHL or I3C; thus, genetic changes affecting Ser37, Thr41 and Ser45 were identified exclusively in the groups given carcinogen and post-treated with either modulator ( Figure  2 , gray boxes). Over half of these mutations (9/17 ϭ 53%) were from groups given DMH or IQ and post-treated with 0.001% CHL. In one group, namely DMH ϩ 0.001% CHL, screening of Ctnnb1 mutations identified substitutions in Ser37, Thr41 or Ser45 residues as the most common type of genetic change (8/10 ϭ 80%). Because this was the group in which a statistically significant increase in colon tumor multiplicity was observed compared with animals given DMH alone (31), we next examined the expression of possible β-catenin/Tcf/ Lef target genes, comparing tumors with wild-type versus mutant forms of β-catenin.
The expression of cyclin D1 mRNA was first examined in six colon tumors containing β-catenin mutations ( Figure 3A , upper panel); a marked increase in cyclin D1 expression was screened by RT-PCR for changes in cyclin D1, c-myc and c-jun ( Figure 3B ). Cyclin D1 was detected in all five tumors but the expression was approximately equivalent to that of To determine whether the changes in mRNA levels were paralleled by alterations in protein expression, the same tumors Hprt in each case (for contrast, see Figure 3A , upper panel). In three of the tumors, c-myc and c-jun mRNA was not were examined by Western blotting ( Figure 3C ). These studies confirmed that in tumors bearing Ctnnb1 mutations (Figure detected, and these genes were only marginally expressed in the remaining two tumors.
3C, lanes 6-10), β-catenin, c-Jun, c-Myc and cyclin D1 proteins were strongly expressed, in marked contrast to normal or CHL exposure may have provided a survival advantage to the cells containing mutant forms of β-catenin with substitutions in colonic mucosa ( Figure 3C, lane 11) . In addition, two of the tumors that were apparently wild-type for Ctnnb1 also showed Ser37, Thr41 or Ser45. Precisely how I3C or CHL might enable survival and clonal expansion of these cells is presently increased levels of β-catenin protein ( Figure 3C , lanes 1 and 2); mutations in other genes, such as Apc, have yet to unclear, but the mechanisms most likely involve the genes controlling cell proliferation and apoptosis in the colonic be examined. None of the tumors with wild-type β-catenin expressed c-Jun or c-Myc at appreciable levels ( Figure 3C , mucosa. We focused on three β-catenin/Tcf/Lef target genes as candidates for further study. A search of the Genebank lanes 1-5). Cyclin D1 was strongly expressed in all tumors, regardless of β-catenin status, except lane 3 which had levels showed that the promoter regions of rat cyclin D1, c-myc and c-jun have perfect Tcf/Lef motifs, like their human comparable with normal colon in lane 11. Scanning densitometry confirmed that, in lanes 6-10, the expression of all four counterparts (13) (14) (15) , and mRNA levels of all three of these genes were markedly overexpressed in colon tumors containing proteins was increased Ͼ10-fold compared with normal colonic mucosa from control rats (data not shown).
mutations in Ctnnb1, and there were strongly elevated levels of β-catenin protein. Interestingly, two of the tumors with codon 41 mutations showed significantly (Ͼ3-fold) higher Discussion amounts of c-Jun compared with three tumors containing mutations in codons 32 or 34 ( Figure 3C , compare lanes 6 This the first study to demonstrate that the spectrum of β-catenin mutations in carcinogen-induced rat colon tumors can and 7 with lanes 8-10). The results suggest that some mutant forms of β-catenin, namely those with direct substitutions be altered by post-initiation exposure to phytochemicals. To our knowledge, it is also the first investigation of β-catenin in critical Ser/Thr residues, may have a greater ability to upregulate c-Jun than others with amino acid substitutions expression and the expression of three β-catenin/Tcf/Lef target genes, namely cyclin D1, c-myc and c-jun, in a subset of adjacent to Ser33. These findings in vivo are supported by previous studies (37) , in which certain mutant forms of β-carcinogen-induced rat colon tumors. A previous study reported on the different frequencies and patterns of β-catenin mutations catenin were more effective than others in activating β-catenin/ Tcf/Lef signaling following transient transfection into cell lines. in liver tumors induced by N-nitrosodiethylamine or a cholinedeficient diet (35) . A second report described a decrease in For the reasons described above, we focused on the expression of candidate β-catenin/Tcf/Lef target genes in the colon β-catenin expression in small intestinal and colon polyps of APC min mice treated with 1,4-phenylene bis(methylene)selenotumors from rats given DMH and 0.001% CHL, but additional studies are now in progress on the colon tumors from other cyanate (36) . However, the finding that there is a shift in the distribution of β-catenin mutations in groups given IQ or DMH groups in this study. The results are anticipated to expand upon those shown in Figure 3 by providing, for each specific and post-treated with CHL or I3C is novel, and has potentially important implications regarding gene-diet interactions and mutant form of β-catenin, quantitative data on gene expression relative to an internal standard (competitor or mimic). The the events that give rise to colon cancers.
In human colorectal cell lines and primary colon cancers, hypothesis is that, with some dietary modulators, tumor promotion involves the selection of particular mutant forms mutations in CTNNB1 usually substitute the critical Ser/Thr residues within the GSK-3β region of β-catenin, namely Ser33, of β-catenin with a more potent ability than others to activate genes controlling key cell proliferation and apoptosis pathways Ser37, Thr41 or Ser45 (3,4), and as a result the β-catenin protein no longer is a substrate for phosphorylation and in the rat colon, and possibly human colon. It is interesting to speculate that the spectrum of β-catenin mutations normally subsequent degradation by the ubiquitin/proteosome pathway (12, 13) . In the present study, none of the colon tumors induced found in human colon cancers might involve initiating events coupled with a selection process, in which dietary constituents by IQ or DMH, in the absence of CHL or I3C treatment, had mutations affecting Ser37, Thr41 or Ser45, and only 2/11 enable cells with certain forms of mutant β-catenin to survive and progress towards tumor formation, when they would (18%) had mutations that substituted Ser33 (Figure 2 ). Previous studies (28-30) of the colon tumors induced by IQ, 2-amino-1-otherwise be deleted by apoptosis. methyl-6-phenylimidazo[4,5-b]pyridine (PhlP), azoxymethane or methylazoxymethanol acetate plus 1-hydroxyanthraquinone
